• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中基因与表观遗传改变的相互作用

Interplay of genetic and epigenetic alterations in hepatocellular carcinoma.

作者信息

Lee Sun-Min, Kim-Ha Jeongsil, Choi Won-Young, Lee Jungwoo, Kim Dawon, Lee Jinyoung, Choi Eunji, Kim Young-Joon

机构信息

Department of Biochemistry, College of Life Science & Technology, Yonsei University, Seoul, Korea.

Department of Integrative Bioscience & Biotechnology, College of Life Sciences, Sejong University, Seoul, Korea.

出版信息

Epigenomics. 2016 Jul;8(7):993-1005. doi: 10.2217/epi-2016-0027. Epub 2016 Jul 14.

DOI:10.2217/epi-2016-0027
PMID:27411963
Abstract

Genetic and epigenetic alterations play prominent roles in hepatocarcinogenesis and their appearance varies depending on etiological factors, race and tumor progression. Intriguingly, distinct patterns of these genetic and epigenetic mutations are coupled not only to affect each other, but to trigger different types of tumorigenesis. The patterns and frequencies of somatic variations vary depending on the nature of the surrounding chromatin. On the other hand, epigenetic alterations often induce genomic instability prone to mutation. Therefore, genetic mutations and epigenetic alterations in hepatocellular carcinoma appear to be inseparable factors that accelerate tumorigenesis synergistically. We have summarized recent findings on genetic and epigenetic modifications, their influences on each other's alterations and putative roles in liver tumorigenesis.

摘要

遗传和表观遗传改变在肝癌发生过程中起着重要作用,其表现因病因、种族和肿瘤进展而异。有趣的是,这些遗传和表观遗传突变的不同模式不仅相互影响,还会引发不同类型的肿瘤发生。体细胞变异的模式和频率因周围染色质的性质而异。另一方面,表观遗传改变常常诱导易于发生突变的基因组不稳定。因此,肝细胞癌中的基因突变和表观遗传改变似乎是协同加速肿瘤发生的不可分割的因素。我们总结了关于遗传和表观遗传修饰的最新发现、它们对彼此改变的影响以及在肝脏肿瘤发生中的假定作用。

相似文献

1
Interplay of genetic and epigenetic alterations in hepatocellular carcinoma.肝细胞癌中基因与表观遗传改变的相互作用
Epigenomics. 2016 Jul;8(7):993-1005. doi: 10.2217/epi-2016-0027. Epub 2016 Jul 14.
2
DNA methylation in hepatocellular carcinoma.肝细胞癌中的DNA甲基化
World J Gastroenterol. 2008 Mar 21;14(11):1741-8. doi: 10.3748/wjg.14.1741.
3
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.表观遗传异常在人类肝细胞癌发生发展中的作用。
Cancer Lett. 2014 Jan 28;342(2):223-30. doi: 10.1016/j.canlet.2012.01.038. Epub 2012 Feb 2.
4
Review of genetic and epigenetic alterations in hepatocarcinogenesis.肝癌发生过程中遗传和表观遗传改变的综述。
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):15-21. doi: 10.1111/j.1440-1746.2005.04043.x.
5
Oxidative stress and epigenetic instability in human hepatocarcinogenesis.氧化应激与人类肝癌发生中的表观遗传不稳定性
Dig Dis. 2013;31(5-6):447-53. doi: 10.1159/000355243. Epub 2013 Nov 21.
6
Genetic alterations in hepatocellular carcinoma: An update.肝细胞癌中的基因改变:最新进展
World J Gastroenterol. 2016 Nov 7;22(41):9069-9095. doi: 10.3748/wjg.v22.i41.9069.
7
Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.纤维化相关的小鼠肝癌发生中的遗传和表观遗传改变。
Int J Cancer. 2014 Jun 15;134(12):2778-88. doi: 10.1002/ijc.28610. Epub 2013 Dec 14.
8
Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.长链非编码RNA、基因组元件的甲基化及其在肝细胞癌中新兴的相互作用
Cancer Lett. 2016 Sep 1;379(2):239-44. doi: 10.1016/j.canlet.2015.08.008. Epub 2015 Aug 14.
9
Current progress in epigenetic research for hepatocarcinomagenesis.肝癌发生的表观遗传学研究的当前进展。
Sci China C Life Sci. 2009 Jan;52(1):31-42. doi: 10.1007/s11427-009-0014-7. Epub 2009 Jan 19.
10
Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.参与HBV/HCV相关肝细胞癌肿瘤发生的表观遗传机制。
Curr Pharm Des. 2014;20(11):1715-25. doi: 10.2174/13816128113199990533.

引用本文的文献

1
Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma.探索肝细胞癌高复发风险的甲基化特征。
Clin Mol Hepatol. 2025 Apr;31(2):563-576. doi: 10.3350/cmh.2024.0899. Epub 2025 Jan 13.
2
Antioxidant Properties of Postbiotics: An Overview on the Analysis and Evaluation Methods.后生元的抗氧化特性:分析与评估方法概述
Probiotics Antimicrob Proteins. 2025 Apr;17(2):606-624. doi: 10.1007/s12602-024-10372-7. Epub 2024 Oct 12.
3
Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy.
乙型肝炎病毒相关肝脏恶性肿瘤的分子和遗传信号作为诊断和治疗靶点的最新进展。
Heliyon. 2024 Jul 8;10(14):e34288. doi: 10.1016/j.heliyon.2024.e34288. eCollection 2024 Jul 30.
4
Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.用于早期检测肝细胞癌特异性生物标志物的生物传感器技术的最新进展:综述
Diagnostics (Basel). 2024 Jul 15;14(14):1519. doi: 10.3390/diagnostics14141519.
5
The Biochemistry and Effectiveness of Antioxidants in Food, Fruits, and Marine Algae.食品、水果和海藻中抗氧化剂的生物化学及功效
Antioxidants (Basel). 2023 Apr 2;12(4):860. doi: 10.3390/antiox12040860.
6
Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples.采用甲基化敏感高分辨率熔解曲线分析技术检测 USP44 启动子能够在血液样本中发现早期肝癌。
BMB Rep. 2022 Nov;55(11):553-558. doi: 10.5483/BMBRep.2022.55.11.110.
7
Epigenetic remodelling in human hepatocellular carcinoma.人类肝细胞癌中的表观遗传重塑。
J Exp Clin Cancer Res. 2022 Mar 24;41(1):107. doi: 10.1186/s13046-022-02297-2.
8
The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.肝细胞癌中转化生长因子-β信号通路的明暗两面:机制、失调及治疗意义
Cancers (Basel). 2022 Feb 14;14(4):940. doi: 10.3390/cancers14040940.
9
Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma.赖氨酸去甲基化酶5C通过表观遗传方式降低ITIH1的转录,从而导致肝细胞癌进展加剧。
Kaohsiung J Med Sci. 2022 May;38(5):437-446. doi: 10.1002/kjm2.12501. Epub 2022 Jan 25.
10
EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.EGF rs4444903 多态性与 HCV 相关肝硬化和 HBV/HCV 相关肝细胞癌的风险相关。
Int J Clin Oncol. 2021 Nov;26(11):2053-2064. doi: 10.1007/s10147-021-01994-w. Epub 2021 Jul 21.